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Objectives: The aim of the study is to determine factors affecting ischaemic wound healing and role of the
angiosome concept in bypass surgery.
Design: Single-centre, retrospective clinical study.
Materials and methods: A total of 249 consecutive critical ischaemic limbs with tissue loss in 228 patients
who underwent distal bypasses from 2003 to 2009 were reviewed. A total of 81% of patients were
diabetic, and 49% of patients had dialysis-dependent renal disease (end-stage renal disease, ESRD). Distal
targets of bypasses were the crural artery (57%) and the pedal artery (43%).
Results: The complete healing of ischaemic wounds was achieved in 211 limbs (84.7%). ESRD (odds ratio
(OR) 0.127, p < 0.001), diabetes (OR 0.216, p ¼ 0.030), Rutherford category 6 (R6) with heel ulcer/
gangrene (OR 0.134, p < 0.001), R6 except heel (OR 0.336, p ¼ 0.025) and low albuminaemia (OR 0.387,
p ¼ 0.049) were negative predictors of wound healing. Regarding the angiosome, the healing rate in the
indirect revascularisation (IR) group was slower than in the direct revascularisation (DR) group, espe-
cially in patients with ESRD (p < 0.001). However, the healing rates of the DR and IR groups were similar
after minimising background differences with propensity score methods (p ¼ 0.185).
Conclusions: In the ﬁeld of bypass surgery, the angiosome concept seems unimportant, at least in non-
ESRD cases. The location and extent of ischaemic wounds as well as co-morbidities may be more rele-
vant than the angiosome in terms of wound healing.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Bypass surgery and endovascular treatment (EVT) are reliable
strategies for revascularisation of critical ischaemic limbs. The ﬁnal
results of the bypass versus angioplasty in severe ischaemia of leg
(BASIL) trial demonstrated that the outcome of bypass surgery after
failed EVT was worse than that of bypass surgery performed as thethe XXVth congress of ESVS,
n 4 of the meeting at Greece.




ciety for Vascular Surgery. Publisheﬁrst line of treatment, which suggested that EVT should not always
be the ﬁrst line of treatment. Thus, additional evidence is needed to
decide how to select the appropriate revascularisation procedure in
daily practice.1 The TransAtlantic Inter-Society Consensus has rec-
ommended that the proﬁle and extent of arterial lesions be used to
select EVT or bypass surgery, while the BASIL trial group favoured
life expectancy.1,2 However, the status of ischaemic wounds and the
healing ability of patients are not regarded as important factors in
selecting revascularisation procedures. The angiosome concept,
introduced by Taylor and Palmer, is also considered an important
factor in wound healing, at least by plastic surgeons and inter-
ventionalists.3e5 Good healing has been achieved by direct endo-
vascular intervention at the artery feeding the angiosome whered by Elsevier Ltd. All rights reserved.
Table 2
Characteristics of distal bypass procedures.
Conduit type
Single vein grafts 163 (66%)
Spliced vein grafts 86 (35%)
Proximal anastomosis
Common femoral 101 (41%)




Anterior tibial 38 (15%)
Posterior tibial 86 (35%)
Peroneal 18 (7%)
Dorsalis pedis 87 (35%)
Plantar 15 (6%)
Other pedal branch 5 (2%)
Adjunctive inﬂow reconstruction
EVTa for iliac artery 24 (10%)
EVT for superﬁcial femoral 4 (2%)
Anatomical bypass 16 (6%)
Extra-anatomical bypass 7 (3%)
a EVT: endovascular treatment.
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surgeons believe that the blood supplied by a bypass graft is
sufﬁcient to ﬁll the entire foot, regardless of the angiosome. The
purpose of this study is to determine the factors affecting ischaemic
wound healing, including the angiosome concept, in the use of
a relatively large patient population.
Materials and Methods
A total of 249 consecutive critical ischaemic limbs with tissue
loss in 228 patients who underwent distal bypass surgery for crural
artery occlusive disease were analysed retrospectively. A total of
81% of patients were diabetic, and 49% of patients had end-stage
renal disease (ESRD), including ﬁve cases of peritoneal dialysis.
The diagnosis of critical limb ischaemia (CLI) was made based on
a non-healing ulcer or gangrene with haemodynamic evidence of
ischaemia by the ankleebrachial pressure index or skin perfusion
pressure (SPP). Clinical characteristics, the status of ischaemic
wounds, operative data and immediate postoperative outcome
data of these patients were registered in the database of our
institution. The patients were entered into a graft surveillance
program (Tables 1 and 2).
We analysed whether the angiosome concept can contribute to
the improvement of outcomes in bypass surgery and evaluated the
efﬁcacy of angiosome-oriented revascularisation itself; 31 limbs of
22 patients who died before healing and nine limbs whose bypass
grafts occluded before healing were excluded.
Ischaemic tissue lesion
All ischaemic wounds were evaluated by the Rutherford clas-
siﬁcation8 immediately before the operation (Table 1). The loca-
tions of the wounds were recorded and their photographs were
taken preoperatively. Bacterial culturewas performed in every case,
and magnetic resonance imaging (MRI) was performed if osteo-
myelitis was suspected.
Revascularisation procedure
All distal bypasses were conducted using vein grafts. A total of
20% of limbs underwent inﬂow reconstruction by EVT or bypass
surgery simultaneously. The anastomotic sites of the distal
bypasses are listed in Table 2. The most common distal anastomosis
was dorsalis pedis. Because the angiosome concept was not yet
recognised at the time of the present study, a disease-free artery
with better runoff was our primary standard for selecting the distalTable 1
Baseline characteristics of patients subjected to healing time analysis.
249 limbs/228 patients
Age 67 (36e91)
Female gender 63 (28%)
Diabetes 184 (81%)
Hypertension 148 (65%)
Coronary artery disease 122 (54%)
ESRD 111 (49%)
Cerebral vascular disease 62 (27%)
Congestive Heart Failure 19 (8%)
Ischaemic tissue loss
Rutherford Classiﬁcation
Category 5 155 (62%)
Category 6 94 (38%)
Single/multiple
Single lesion 72 (29%)
Multiple lesions 177 (71%)
ESRD: end-stage renal disease.target artery. The conduits of grafts are also listed in Table 2. The in
situ saphenous veins were used most frequently. For the patients
who did not have a good saphenous vein, the short saphenous vein,
arm vein, or in some cases, femoral vein was used, but the artiﬁcial
grafts were never used in the infrapopliteal area.
Postoperative wound care and additional procedure for wound
healing
Necrotic tissues were debrided immediately after the bypass
procedure. A total of 49% of limbs underwent minor amputation.
After minor amputation, most wounds were left open, and thenwe
waited for the disappearance of infection signs and the growth of
granulation tissues. Negative pressure treatments using vacuum-
assisted devices were applied to most of the deep wounds that
reached tendons or bones, and recombinant basic ﬁbroblast growth
factor (Fiblast Spray, Kaken Pharmaceutical Co., Ltd., Tokyo, Japan)
was used to facilitate epithelialisation in most wounds. A total
of 17% of limbs underwent skin grafting. Free ﬂap transfers, such
as with scapular, latissimus dorsi, or rectus musculocutaneous
ﬂaps, were performed in 6% of patients to cover extensive tissue
defects.
Deﬁnition of wound healing
Complete wound healing was deﬁned by the achievement of
complete epithelialisation of all wounds in their affected limbs. The
duration from the initial bypass surgery to complete epithelialisa-
tion was deﬁned as the healing time. If the ulcer recurred within 2
months after epithelialisation, the diagnosis of complete healing
was rescinded; otherwise, the observation of wounds was termi-
nated for the calculation of the wound healing time. The ‘end’ point
of this study was clinical success deﬁned by complete wound
healing; therefore healing that took more than 1 year, death before
complete healing or major amputation was deﬁned as clinical
failure. In patients who underwent major amputations, the healing
time was considered to be inﬁnite (which was treated as >25
months in the statistical analysis).
Deﬁnitions of direct (DR) and indirect revascularisation (IR)
The judgement of direct (DR) or indirect revascularisation (IR)
was made by collating the location of ischaemic tissue loss with the
Table 3
Univariate and multivariate analysis of freedom from clinical failure.a
Factors Univariate analysis Multivariate analysis
p-value Odds ratio (95% CI) p-value
ESRD <0.001 0.13 (0.048e0.338) <0.001
Diabetes <0.05 0.22 (0.054e0.859) 0.030
Albumin < 3b g/dL <0.001 0.39 (0.150e0.996) 0.049
CRP > 5b mg/dL <0.001 0.9 (0.355e2.277) 0.822
Heel ulcer/gangrene <0.001 0.13 (0.051e0.350) <0.001
R6 except heelc <0.05 0.34 (0.130e0.871) 0.025
CI: conﬁdence interval.
a Delay healing more than one year, death before complete healing, or major
amputation was deﬁned as clinical failure.
b Lowest quaterile value approximation.
c Tissue loss categorised Rutherford 6 except in the heel.
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feeding artery of the affected angiosome was revascularised, while
IR was assigned if the revascularised artery fed unrelated angio-
somes. As an exception, in accordance with a previous report,
revascularisation of digit ulcers by the dorsalis pedis or plantar
artery was considered as DR, regardless of whether the ulcer was
located on the dorsal side or plantar side.9
Statistical analysis
Statistical analysis was performed using PASW statistics version
18, formerly called SPSS statistics (SPSS Inc., Chicago, IL, USA).
Continuous variables are reported as the median values with
ranges. TheManneWhitney test and chi-squared test were used for
univariate analysis. The graft patency, limb salvage, survival and
ulcer healing rate were calculated using KaplaneMeier methods,
and the curves were compared by the log-rank test. Because the
healing time of the patients who underwent major amputationwas
considered to be inﬁnite, a multivariate logistic regression model
was used to determine the predictors of ‘end’ points.
In analysing the angiosome, there were signiﬁcant differences
between the DR and IR groups in terms of patient background,
severity of ischaemic tissue loss and infection. To minimise these
background differences between the DR and IR groups and better
assess the role of the angiosome concept, we employed propensity
score methods. A logistic regression analysis model to estimate the
likelihood of undergoing DR or IR revascularisation was created.
The covariates entered into themodel included diabetes, ESRD, heel
ulcer, Rutherford classiﬁcation and serum albumin and CRP levels.
The propensity score calculated according to the logistic regression
model was employed for one-to-one matching according to a less
than 0.03 difference in the propensity score between the DR and IR
groups. In all analyses, p < 0.05 was considered statistically
signiﬁcant.
Results
The operative death rate was 0.9% due to cardiac events. The
overall cumulative primary and secondary patency rates of bypass
grafts were 61.4%, and 86.5% at 2 years, respectively.
Limb salvage
The cumulative limb salvage rate at 2 years was 93.1%. A total of
70% of limb losses were due to uncontrollable infection or
infection-related graft problems.
Ulcer healing time
The complete healing of ischaemic wounds was achieved in 211
limbs (84.7%). The cumulative wound healing rate was 72.2% at 6
months and 86.9% at 1 year. The median ulcer healing time was 47
days in non-ESRD patients with Rutherford category (R) 5, 73 days
in ESRD patients with R5, 115 days in non-ESRD patients with R6
and 237 days in ESRD patients with R6.
The location of the ulcer (heel), extensive tissue loss deﬁned by
R6, diabetes, ESRD, CRP and severely low albuminaemia (deﬁned as
<3.0 g dL1) were the factors inhibiting clinical success according
to the univariate analysis, while ESRD (odds ratio (OR) 0.127), dia-
betes (OR 0.216), low albuminaemia (OR 0.387), R6 with heel ulcer/
gangrene (OR 0.134) and R6 except in the heel (OR 0.336) were the
factors predicting clinical failure according to multivariate analysis
(Table 3).
According to the results of the multivariate analysis, limbs with
ischaemic tissue loss were divided into three groups: non-ESRD,ESRD without severely low albuminaemia (ESRDnorAlb) and
ESRD with severely low albuminaemia (ESRDlowAlb). The wound
healing rate of the ESRDlowAlb group was signiﬁcantly worse
compared to the other groups (p < 0.001), while that of the
ESRDnorAlb group was acceptable (Fig. 1).
Amputation-free survival
The amputation-free survival (AFS) of the ESRDlowAlb group
was signiﬁcantly worse compared to the other groups (p < 0.001)
(Fig. 2).
Role of angiosome
A total of 218 limbs were used for further analysis (Table 4). The
healing rate of the DR group was signiﬁcantly faster compared to
the IR group among non-ESRD patients (p ¼ 0.01), while the limb
salvage rate of both the DR and IR groups among non-ESRD patients
was 100% at 12 months (N.S., Fig. 3(A)). In ESRD patients, on the
other hand, the IR group was markedly worse compared with the
DR group in terms of the healing rate (p < 0.001) and the limb
salvage rate (p ¼ 0.0032, Fig. 3(B)).
However, the differences between the DR and IR groups in terms
of patient background and the characteristics of the ischaemic
wounds, such as their extent and infection, were problematic
(Table 4). To resolve this problem regarding background bias, the
propensity score method was employed. Then 48 matched pairs
were taken for further statistical analysis. After matching according
to the propensity score, the differences between the DR and IR
groups were minimised (Table 4). The wound healing rate in the
IR group after matching was slightly slower than that of the DR
group, but this observation did not reach statistical signiﬁcance
(p¼ 0.185) (Fig. 4). The limb salvage rates of the DR and IR groups in
matched pairs were 97.8% and 92.3% at 2 years, respectively
(p ¼ 0.855).
Discussion
The present study represents one of the largest investigations of
ischaemic ulcer healing after bypass surgery. To our knowledge,
this is the ﬁrst detailed description of ulcer healing in a relatively
large population of patients with dialysis-dependent ESRD.
Furthermore, this study attempts to address the role of the angio-
some in the ﬁeld of bypass surgery, and our ﬁndings suggest that
the angiosome concept is not highly important in the ﬁeld of bypass
surgery in most non-ESRD patients, contrary to previous reports.
Wound healing after revascularisation has been not fully studied
even though it is one of the most important outcomes of CLI
treatment. Although there are only few studies describing in detail
Figure 1. Cumulative healing rate of ischaemic tissue defects after distal bypass surgery in different groups categorised according to patient background. Non-ESRD: limbs in
patients without ESRD; ESRDnorAlb: limbs in ESRD patients without severely low albuminaemia; ESRDlowAlb: limbs in ESRD patients with severely low albuminaemia (<3.0 g/dL).
There was a signiﬁcant difference among groups (p < 0.001 by the log-rank test).
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factors have been reported to inhibit wound healing after revas-
cularisation: (1) the location and extent of ischaemic tissue
defects,10e13 (2) systemic factors relating to wound healing ability
and the defence system,10,14 (3) infection,15 (4) inadequate topical
treatment15,16 and (5) insufﬁcient blood supply due to inappro-
priate revascularisation.15,17
One of the co-morbidities that affect wound healing is diabetes,
which also impairs the host defence system against infection.
Moreover, microcirculation disorders are common in diabetic
patients. Apelqvist et al. criticised that studies with regard to
vascular intervention have focussed on limb salvage, indicating
a need to recognise and introduce decreased perfusion and
impaired circulation.10 In our series, diabetes was one of the risk
factors for prolonged tissue healing time, which is supported by
previous ﬁndings.14
ESRDwas the strongest factor in predicting clinical failure in our
series. Many authors already reported the high amputation rate in
ESRD patients regardless of patent grafts, and concluded that the
failure of foot salvage in this patient population was due to wound
healing problems rather than graft thrombosis, although no studies
have offered a precise description of wound healing after bypass
surgery.15,18,19 The present study is the ﬁrst to report the cumulative
ulcer healing rate of patients with ESRD. The median ulcer healing
time was 73 days in ESRD patients with R5 tissue loss, whereas it
was 237 days in ESRD patients with R6 tissue loss, suggesting that
early referral to a vascular specialist is crucial to achieve clinical
success in CLI patients with ESRD.Previous studies recommended that bypass surgery for ESRD
patients should be performed only in carefully selected patients,
because of their poor outcomes.15,20 However, guidelines describing
how to select optimal ESRD patients for bypass surgery are rarely
reported.21 Our data clearly show that serum albumin level was
a strong predictor of whether an ESRD patient would be a good or
bad responder to bypass surgery. The correlation between serum
albumin level and life prognosis in ESRD patients is well estab-
lished,19 and the hypoalbuminaemia is most likely caused by
inﬂammation, not by malnutrition.22,23 ESRD with low albu-
minaemia ﬁts the model proposed by the authors of the BASIL trial
as a patient group with a life expectancy less than 2 years.1 On the
other hand, ESRD patients without low albuminaemina tolerated
bypass surgery well, and their wound healing rate and AFS were
acceptable. In this context, ESRD patients with CLI seem non-
homogeneous; therefore, proper patient selection may be impor-
tant before planning revascularisation.
The angiosome concept is widely accepted by interventionalists
to improve outcomes, and several retrospective studies have re-
ported that the outcomes of angiosome-oriented EVT were better
than those of indirect treatmnt.6,7 This advantage seems reasonable
because the blood supply through one diseased tibial artery that
undergoes EVT may be limited. In the ﬁeld of bypass surgery,
Neville et al. also reported a large difference between DR and IR in
terms of limb salvage.17 However, many vascular surgeons may
criticise their results, because vascular surgeons believe that the
blood supplied by bypass graft anastomosed to one foot artery is
sufﬁcient to ﬁll the entire foot regardless of the angiosome. Neville
Figure 2. Cumulative amputation-free survival rate according to patient background. Non-ESRD: patients without ESRD; ESRDnorAlb: ESRD patients without severely low albu-
minaemia; ESRDlowAlb: ESRD patients with severely low albuminaemia (<3.0 g/dL). There was a signiﬁcant difference among groups (p < 0.001 by log-rank test).
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between their DR and IR groups, but they did not mention the
difference in ischaemic wound status between groups. Angiosome-
guided bypass surgery is not always possible because infection,
extensive tissue loss and severe arterial disease sometimes
preclude DR. The present study found signiﬁcant differences
between the DR and IR groups in terms of CRP and albumin levels,
the location and extent of tissue defects and the bypass target
artery, reﬂecting the disadvantageous condition of the IR group.Table 4
Baseline characteristics and operative data of patients subjected to angiosome analysis.
Overall series
DR group IR group
126 limbs 92 limbs
Age 66.5 (39e91) 67.5 (46e86)
Female gender 32 (26%) 24 (26%)
Diabetes 101 (80%) 74 (80%)
ESRD 67 (53%) 41 (44%)
Serum albumina 3.4 (2.2e4.9) 3.3 (1.6e4.2)
CRPb 0.9 (27.8) 3.2 (30.1)
Rutherford 6 20 (16%) 59 (64%)
Heel ulcer/gangrene 6 (5%) 30 (32%)
Bypass target
Crural 60 (48%) 69 (75%)
Pedal 66 (52%) 23 (25%)
Propensity score
DR: direct revascularisation, IR: indirect revascularisation in terms of angiosome, ESRD:
a g/dL.
b Only maximum values are listed. Minimum value of CRP was <0.1 mg/dL.Our data demonstrate the shortcoming of direct comparisons
between IR and DR. Thus, we employed propensity score methods.
After minimising background differences between propensity
score-matched groups, no difference between the DR and IR groups
in terms of limb salvage rate or wound healing rate was found,
suggesting that the angiosome concept seems unimportant in the
ﬁeld of bypass surgery, unlike the EVT ﬁeld. In other words,
surgeons do not have to approach a neighbouring infectious area or
a severely diseased artery and risk graft failure. The results of ourPropensity score-matched pairs
p-value DR group IR group p-value
48 limbs 48 limbs
0.434 67.5 (54e91) 67.5 (53e86) 0.849
0.908 18 (38%) 12 (25%) 0.186
0.960 38 (79%) 36 (75%) 0.627
0.209 22 (46%) 18 (38%) 0.408
0.001 3.3 (2.2e4.2) 3.35 (2.2e4.2) 0.942
0.004 1.96 (27.8) 2.14 (18.1) 0.852
<0.001 20 (42%) 18 (38%) 0.676
<0.001 6 (13%) 8 (17%) 0.772
<0.001 30 (63%) 33 (69%) 0.519
18 (38%) 15 (31%)
0.6239 0.6295 0.982
end-stage renal disease.
Figure 4. Cumulative healing rate in propensity score-matched pairs. There was no signiﬁcant difference between the DR group and IR group (p ¼ 0.185). DR: direct revascu-
larisation. IR: indirect revascularisation.
Figure 3. Cumulative healing rate in different bypass strategies based on the angiosome concept. 3A: DR versus IR in non-ESRD patients (p ¼ 0.01). 3B: DR versus IR in ESRD
patients (p < 0.001). DR: direct revascularisation. IR: indirect revascularisation.
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artery of bypass surgery in patients with ischaemic tissue loss.
Based on our data, we believe that a good arterywith good runoff to
the foot, regardless of the angiosome, should be selected in non-
ESRD patients, which may allow bypass surgery to be more bene-
ﬁcial in the long term. On the other hand, angiosome-oriented
target selection might improve the poorer outcomes in ESRD
patients. We did not investigate whether the collateral develop-
ment was sufﬁcient, or whether the arterial disease involved the
connecting arteries between angiosomes. The poorer outcomes in
the IR group among these ESRD patients might suggest that the
severe arterial disease involved the connecting arterial network in
some ESRD patients. Further studies investigating the haemody-
namic changes in angiosomes after bypass surgery by SPP
measurement, as well as the morphological connections between
angiosomes by precise completion angiography or indocyanine
green staining, are needed to clarify the role of the angiosome in
patients with ESRD.
Our study has some limitations. First, this was a single-centre,
retrospective study. Second, the population for the angiosome
analysis had been reduced after propensity score matching.
Although the propensity score method was useful to minimise
background differences, hidden bias may remain. Therefore, larger-
scale, prospective studies are needed to conﬁrm our results.Conclusions
In the ﬁeld of bypass surgery, the angiosome concept seems
unimportant in non-ESRD cases, while it is still not clear whether
angiosome-guided bypass grafting improves the wound healing of
ESRD patients. The location and extent of ischaemic wounds, as
well as co-morbidities such as diabetes, ESRD and low albu-
minaemia, might be more relevant in terms of wound healing after
bypass surgery. Patients with ESRD with low albuminaemia are not
good candidates for bypass surgery because of poor wound healing
and AFS, while ESRD patients without low albuminaemia can be
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